idarubicinol has been researched along with epirubicin in 5 studies
| Studies (idarubicinol) | Trials (idarubicinol) | Recent Studies (post-2010) (idarubicinol) | Studies (epirubicin) | Trials (epirubicin) | Recent Studies (post-2010) (epirubicin) |
|---|---|---|---|---|---|
| 54 | 10 | 0 | 5,453 | 1,838 | 1,570 |
| Protein | Taxonomy | idarubicinol (IC50) | epirubicin (IC50) |
|---|---|---|---|
| Genome polyprotein | 0.75 | ||
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 5.181 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ames, MM; Kuffel, MJ; Reid, JM | 1 |
| Amadori, D; Dollbaum, C; Hackett, AJ; Hiller, A; Lippman, M; Mayall, B; Smith, HS; Swain, S; Volpi, A; Zoli, W | 1 |
| Robert, J; Schott, B | 1 |
| Aita, P; Bearz, A; Boiocchi, M; Colussi, AM; Corona, G; Crivellari, D; Robieux, I; Sorio, R; Stocco, F; Toffoli, G | 1 |
| Bengala, C; Biadi, O; Conte, PF; Danesi, R; Del Tacca, M; Donati, S; Favre, C; Fogli, S; Guarneri, V; Innocenti, F; Mariani, M; Pazzagli, I | 1 |
1 trial(s) available for idarubicinol and epirubicin
| Article | Year |
|---|---|
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Cyclophosphamide; Daunorubicin; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Idarubicin; Maximum Tolerated Dose; Methotrexate; Middle Aged; Neoplasm Metastasis; Paclitaxel; Taxoids; Time Factors | 2000 |
4 other study(ies) available for idarubicinol and epirubicin
| Article | Year |
|---|---|
Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.
Topics: Antibiotics, Antineoplastic; Cell Division; Daunorubicin; DNA Damage; DNA, Neoplasm; Doxorubicin; Epirubicin; Glioma; Humans; Idarubicin; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1992 |
Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Survival; Cisplatin; Daunorubicin; Doxorubicin; Epirubicin; Humans; In Vitro Techniques; Prognosis; Tumor Cells, Cultured; Vinblastine | 1990 |
Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in culture.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Resistance; Epirubicin; Glioma; Rats; Tumor Cells, Cultured | 1989 |
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Daunorubicin; Deoxycytidine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Idarubicin; Melphalan; Middle Aged; Neoplasm Metastasis; Paclitaxel; Remission Induction; Taxoids; Thiotepa; Time Factors; Transplantation Conditioning; Treatment Outcome | 2003 |